Texas Attorney General Ken Paxton launched an investigation into Deepshek, a Chinese artificial intelligence startup that shook Wall Street last month, claiming it is violating the state's data privacy laws.
Republican AG said Deepshek's “blatant loyalty to the Chinese Communist Party (CCP)” “seems to be merely a proxy for undermining American AI control and stealing civil data.” Ta.
The controversial company requires cooperation with the government intelligence reporting agency, and is subject to Chinese law that could potentially compromise your personal data, and is subject to Texas data privacy and security laws. He added that he notified DeepSeek that he was violating it.
He also ordered Google and Apple to give them an internal analysis of Deepseek's AI chatbot app and all the documents the company needs to submit before it appears in their respective app stores.
“I am urging Google and Apple to cooperate immediately by publishing a thorough investigation and providing all relevant documents related to the DeepSeek app,” Paxton posted.
“The US and Texas remain at the forefront of global AI innovation, and companies lined up with CCPs that violate Texans' rights and undermine their control by illegally burdening American technology companies, are now fully in law. I face a lot of strength.”
Last month, Paxton banned AI assistants on all devices in his office due to national security concerns and the risks that promote CCP propaganda and censorship.
This week with New York Governor Kathy Hochul Virginia Governor Glenn Youngkin It followed that by banning Deepseek on all devices and networks in the state.
But President Trump was more optimistic about the emergence of Deepshek, saying that Silicon Valley should be innovated.
“The release of Deepseek AI from Chinese companies should be an industry awakening call that has to focus on lasers by competing to win, as we have the world's greatest scientists,” Trump said. I said last month when it was low. – The cost chatbot has been launched.
Paxton has pursued aggressive litigation in the past, including investigations of high-tech companies on privacy and safety concerns and complaints from pharmaceutical companies regarding potential deceptive trade practices in the marketing of Covid-19 vaccines. .
